Do analysts recommend VSEE or AIFF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate VSEE or HCTI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Healthcare Triangle 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer ACON or VSEE?

Aclarion currently has a consensus price target of $7.50, suggesting a potential upside of 286.60%. Given Aclarion's stronger consensus rating and higher probable upside, equities analysts plainly believe Aclarion is more favorable than VSee Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ACON or VSEE more profitable?

VSee Health has a net margin of -92.36% compared to Aclarion's net margin of -10,948.81%. Aclarion's return on equity of -59.34% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion -10,948.81% -59.34% -56.12% VSee Health -92.36% -11,636.34% -68.62%

Do analysts prefer ITOC or VSEE?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, ITOC or VSEE?

Itonic has higher earnings, but lower revenue than VSee Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Itonic $556.43K 49.96 -$5.10M N/A N/A VSee Health $14.46M 0.47 -$14.71M -$0.37 N/A

Is ITOC or VSEE more profitable?

Itonic has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Itonic's return on equity of 0.00% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets Itonic N/A N/A N/A VSee Health -92.36% -11,636.34% -68.62%

Do analysts recommend VSEE or ?

Given 's higher possible upside, analysts clearly believe is more favorable than VSee Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, VSEE or ?

has lower revenue, but higher earnings than VSee Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VSee Health $14.46M 0.47 -$14.71M -$0.37 N/A N/A N/A N/A N/A N/A

Is VSEE or more profitable?

has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. 's return on equity of 0.00% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets VSee Health -92.36% -11,636.34% -68.62% N/A N/A N/A

VSee Health (VSEE) Competitors

$1.90 -0.05 (-2.56%)

As of 10/13/2026

Compare

VSEE vs. AIFF, HCTI, ACON, ITOC, and PTHL

Should you buy VSee Health stock or one of its competitors? VSee Health's main competitors and comparable companies include Firefly Neuroscience (AIFF), Healthcare Triangle (HCTI), Aclarion (ACON), Itonic (ITOC), and Pheton (PTHL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does VSee Health compare to Firefly Neuroscience?

VSee Health (NASDAQ:VSEE) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

In the previous week, Firefly Neuroscience had 3 more articles in the media than VSee Health. MarketBeat recorded 3 mentions for Firefly Neuroscience and 0 mentions for VSee Health. Firefly Neuroscience's average media sentiment score of 0.55 beat VSee Health's score of 0.00 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company	Overall Sentiment
VSee Health	Neutral
Firefly Neuroscience	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

VSee Health has higher revenue and earnings than Firefly Neuroscience. VSee Health is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.47	-$14.71M	-$0.37	N/A
Firefly Neuroscience	$1.14M	14.73	-$19.88M	-$0.59	N/A

VSee Health has a net margin of -92.36% compared to Firefly Neuroscience's net margin of -506.23%. Firefly Neuroscience's return on equity of -90.17% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
Firefly Neuroscience	-506.23%	-90.17%	-72.05%

1.0% of VSee Health shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 14.9% of VSee Health shares are held by company insiders. Comparatively, 6.9% of Firefly Neuroscience shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

VSee Health and Firefly Neuroscience tied by winning 6 of the 12 factors compared between the two stocks.

How does VSee Health compare to Healthcare Triangle?

VSee Health (NASDAQ:VSEE) and Healthcare Triangle (NASDAQ:HCTI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Healthcare Triangle	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Healthcare Triangle has a net margin of -66.85% compared to VSee Health's net margin of -92.36%. Healthcare Triangle's return on equity of -125.45% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
Healthcare Triangle	-66.85%	-125.45%	-36.06%

1.0% of VSee Health shares are held by institutional investors. Comparatively, 0.3% of Healthcare Triangle shares are held by institutional investors. 14.9% of VSee Health shares are held by insiders. Comparatively, 0.1% of Healthcare Triangle shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Healthcare Triangle had 3 more articles in the media than VSee Health. MarketBeat recorded 3 mentions for Healthcare Triangle and 0 mentions for VSee Health. Healthcare Triangle's average media sentiment score of 0.27 beat VSee Health's score of 0.00 indicating that Healthcare Triangle is being referred to more favorably in the news media.

Company	Overall Sentiment
VSee Health	Neutral
Healthcare Triangle	Neutral

Healthcare Triangle has lower revenue, but higher earnings than VSee Health. VSee Health is trading at a lower price-to-earnings ratio than Healthcare Triangle, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.47	-$14.71M	-$0.37	N/A
Healthcare Triangle	$13.89M	0.41	-$9.48M	-$33.52	N/A

Summary

Healthcare Triangle beats VSee Health on 6 of the 11 factors compared between the two stocks.

How does VSee Health compare to Aclarion?

Aclarion (NASDAQ:ACON) and VSee Health (NASDAQ:VSEE) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Aclarion has higher earnings, but lower revenue than VSee Health. VSee Health is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$80K	69.84	-$7.23M	-$7.40	N/A
VSee Health	$14.46M	0.47	-$14.71M	-$0.37	N/A

VSee Health has a net margin of -92.36% compared to Aclarion's net margin of -10,948.81%. Aclarion's return on equity of -59.34% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,948.81%	-59.34%	-56.12%
VSee Health	-92.36%	-11,636.34%	-68.62%

Aclarion currently has a consensus price target of $7.50, suggesting a potential upside of 286.60%. Given Aclarion's stronger consensus rating and higher probable upside, equities analysts plainly believe Aclarion is more favorable than VSee Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Aclarion had 5 more articles in the media than VSee Health. MarketBeat recorded 5 mentions for Aclarion and 0 mentions for VSee Health. Aclarion's average media sentiment score of 0.78 beat VSee Health's score of 0.00 indicating that Aclarion is being referred to more favorably in the media.

Company	Overall Sentiment
Aclarion	Positive
VSee Health	Neutral

7.5% of Aclarion shares are held by institutional investors. Comparatively, 1.0% of VSee Health shares are held by institutional investors. 0.0% of Aclarion shares are held by insiders. Comparatively, 14.9% of VSee Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Aclarion beats VSee Health on 11 of the 15 factors compared between the two stocks.

How does VSee Health compare to Itonic?

Itonic (NASDAQ:ITOC) and VSee Health (NASDAQ:VSEE) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Itonic has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Itonic's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
VSee Health	-92.36%	-11,636.34%	-68.62%

Itonic has higher earnings, but lower revenue than VSee Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$556.43K	49.96	-$5.10M	N/A	N/A
VSee Health	$14.46M	0.47	-$14.71M	-$0.37	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Itonic had 4 more articles in the media than VSee Health. MarketBeat recorded 4 mentions for Itonic and 0 mentions for VSee Health. Itonic's average media sentiment score of 0.16 beat VSee Health's score of 0.00 indicating that Itonic is being referred to more favorably in the media.

Company	Overall Sentiment
Itonic	Neutral
VSee Health	Neutral

1.0% of VSee Health shares are held by institutional investors. 14.9% of VSee Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Itonic beats VSee Health on 7 of the 10 factors compared between the two stocks.

How does VSee Health compare to ?

VSee Health (NASDAQ:VSEE) and (:) are related companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

1.0% of VSee Health shares are held by institutional investors. 14.9% of VSee Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Given 's higher possible upside, analysts clearly believe is more favorable than VSee Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. 's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
	N/A	N/A	N/A

In the previous week, had 1122 more articles in the media than VSee Health. MarketBeat recorded 1122 mentions for and 0 mentions for VSee Health. VSee Health's average media sentiment score of 0.00 equaled 'saverage media sentiment score.

Company	Overall Sentiment
VSee Health	Neutral
	Neutral

has lower revenue, but higher earnings than VSee Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.47	-$14.71M	-$0.37	N/A
	N/A	N/A	N/A	N/A	N/A

Summary

beats VSee Health on 5 of the 9 factors compared between the two stocks.

Get VSee Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VSEE vs. The Competition

Export

Metric	VSee Health	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$6.84M	$1.90B	$7.18B	$13.18B
Dividend Yield	N/A	3.94%	2.52%	19.59%
P/E Ratio	-3.52	18.58	215.33	19.57
Price / Sales	0.47	91.99	571.63	81.29
Price / Cash	N/A	32.17	76.68	52.75
Price / Book	-190.00	5.88	10.37	5.92
Net Income	-$14.71M	-$19.09M	$3.50B	$380.90M
7 Day Performance	-4.81%	-1.04%	-3.49%	-3.90%
1 Month Performance	82.69%	-2.40%	-7.76%	-6.42%
1 Year Performance	-96.05%	-21.61%	0.82%	-6.01%

VSee Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VSEE VSee Health	N/A	$1.90 -2.6%	N/A	-96.0%	$6.84M	$14.46M	N/A	N/A	Gap Down
AIFF Firefly Neuroscience	0.2736 of 5 stars	$1.25 -3.8%	N/A	-61.1%	$20.40M	$1.14M	N/A	17
HCTI Healthcare Triangle	0.6058 of 5 stars	$0.56 -8.4%	N/A	-99.8%	$9.09M	$25.67M	N/A	58	Short Interest Increase
ACON Aclarion	3.6214 of 5 stars	$2.29 -2.1%	$7.50 +227.5%	-78.3%	$6.75M	$83.77K	N/A	11	Short Interest Decrease
ITOC Itonic	0.3163 of 5 stars	$4.11 +1.3%	N/A	N/A	$4.32M	$520K	N/A	7

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VSEE) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

VSee Health (VSEE) Competitors

VSEE vs. AIFF, HCTI, ACON, ITOC, and PTHL

How does VSee Health compare to Firefly Neuroscience?

Summary

How does VSee Health compare to Healthcare Triangle?

Summary

How does VSee Health compare to Aclarion?

Summary

How does VSee Health compare to Itonic?

Summary

How does VSee Health compare to ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VSEE vs. The Competition

VSee Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

VSee Health (VSEE) Competitors

VSEE vs. AIFF, HCTI, ACON, ITOC, and PTHL

How does VSee Health compare to Firefly Neuroscience?

Does the media prefer VSEE or AIFF?

Do analysts recommend VSEE or AIFF?

Which has stronger valuation & earnings, VSEE or AIFF?

Is VSEE or AIFF more profitable?

Do insiders and institutionals have more ownership in VSEE or AIFF?

Summary

How does VSee Health compare to Healthcare Triangle?

Do analysts rate VSEE or HCTI?

Is VSEE or HCTI more profitable?

Do institutionals & insiders hold more shares of VSEE or HCTI?

Does the media prefer VSEE or HCTI?

Which has higher earnings & valuation, VSEE or HCTI?

Summary

How does VSee Health compare to Aclarion?

Which has preferable earnings & valuation, ACON or VSEE?

Is ACON or VSEE more profitable?

Do analysts prefer ACON or VSEE?

Does the media favor ACON or VSEE?

Do institutionals & insiders have more ownership in ACON or VSEE?

Summary

How does VSee Health compare to Itonic?

Is ITOC or VSEE more profitable?

Which has stronger valuation & earnings, ITOC or VSEE?

Do analysts prefer ITOC or VSEE?

Does the media prefer ITOC or VSEE?

Do insiders & institutionals have more ownership in ITOC or VSEE?

Summary

How does VSee Health compare to ?

Do institutionals & insiders believe in VSEE or ?

Do analysts recommend VSEE or ?

Is VSEE or more profitable?

Does the media favor VSEE or ?

Which has preferable valuation and earnings, VSEE or ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VSEE vs. The Competition

VSee Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools